Syncope and falls due to timolol eye dropsBMJ 2006; 332 doi: http://dx.doi.org/10.1136/bmj.332.7547.960 (Published 20 April 2006) Cite this as: BMJ 2006;332:960
- Marije E Müller, consultant physician in internal and geriatric medicine1,
- Nathalie van der Velde, postdoctorate resident in geriatric medicine2,
- Jaap W M Krulder, consultant physician in internal and geriatric medicine2,
- Tischa J M van der Cammen, head of department (firstname.lastname@example.org)2
- 1 Department of Geriatric Medicine, Albert Schweitzer Hospital, PO Box 444, 3300 AK Dordrecht, Netherlands
- 2 Department of Geriatric Medicine, Erasmus MC, Room D442, PO Box 2040, 3000 CA Rotterdam, Netherlands
- Correspondence to: TJMvander Cammen
- Accepted 8 October 2005
The prevalence of glaucoma increases with age.1 Timolol, a non-selective β blocker, is the first line treatment. We present three cases from our falls clinic, in which we show that even a low dose of timolol eye drops may cause severe systemic adverse effects.
A 73 year old man was referred by his general practitioner because he had been unconscious for half an hour the previous day. His medical history consisted of a myocardial infarction, glaucoma, and insulin dependent diabetes mellitus. During the past few years, he had experienced four spells of dizziness with severe perspiration. These spells had been ascribed to hypoglycaemia, although low blood glucose values had never been detected. His medication consisted of insulin, acenocoumarol, alfuzosin, and timolol eye drops (0.5%, twice daily in both eyes). During his last dizzy spell, his blood glucose concentration had been 8 mmol/l. According to his wife, the patient had not experienced a convulsion, tongue biting, or urinary incontinence.
At referral to our clinic, the patient was alert and feeling well. Blood pressure was 142/90 mm Hg, with a regular pulse rate of 48 beats/min. There was no evidence of orthostatic hypotension. Further physical examination, including neurological examination, showed no abnormalities. Glycated haemoglobin (HbA1c) was slightly increased—8.2% (reference range 4-6%); the glucose day curve showed values of 4.6-17.4 (3.5-11) mmol/l, with no hypoglycaemia. Electrocardiography showed sinus bradycardia of 41 beats/min, and 24 hour Holter monitoring showed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial